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Abstract 
 
For the study of neuromodulation in Cancer borealis we have designed a microfluidic 
device to separate and detect bioamine concentrations with a high temporal resolution. 
Our goal is to use this device to measure the concentration of continuous bioamine 
microdialysis samples directly from the pericardial cavity (the area surrounding the heart) 
of Cancer borealis.  The microfluidic device that we designed is made from 
polydimethylsiloxane (PDMS) and exhibits an off-channel configuration of capillary 
electrophoresis (CE) by incorporating micellar electrokinetic chromatography 
(MEKC).  CE is used to separate bioamines based on charge and size due to the applied 
electrical potential. In the off-channel configuration, the potential is applied across the 
separation channel and grounded by the palladium decoupler, which lies just before the 
detector. Microchip CE is advantageous because it uses small amounts of analyte and 
completes fast run times. We will use MEKC to separate dopamine and octopamine, 
since they are structural isomers, by their difference in affinity to sodium dodecyl sulfate 
(SDS) micelles.  This results in different elution times for dopamine and octopamine. 
We were able to drive the fluid in the correct direction. The creation of this device has 
valuable implications, allowing for baseline concentrations of neuromodulators with the 
Cancer borealis to be established.  The effect of different stimuli on these crabs can then 
be more accurately determined.  
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1 Introduction 
 
This project involves an interdepartmental effort between Dr. Ashley Kim’s lab 
(bioengineering), Dr. Steven Suljak’s lab (chemistry), and Dr. John Birmingham’s lab 
(physics) to study the effects of neuromodulators (chemical signals released by neurons 
used to control the muscles of the organism) common to the crab Cancer borealis.  The 
goal is to study how different stimuli affect the neuromodulators of the crab.  In order to 
do this, it is necessary to create a device that has a high temporal resolution to measure an 
accurate baseline. 
 
Research done by an earlier group has focused on the concentrations of neuropeptides 
and their correlation with physiological changes in Cancer borealis
1
. This background 
provided us with a foundation for our proposed work, so that we could focus on the 
analysis and measurement of these neuromodulators and more precisely quantify the 
reactions of Cancer borealis in different environments. This particular crab species 
serves as a simple model organism, allowing us to study the effects of these 
neurohormones using only a small range of stimuli. 
 
In order to obtain our sample data, we designed and manufactured a microfluidic device 
that can detect the presence of very small concentrations of dopamine, norepinephrine, 
octopamine, serotonin, tyramine, and gama-aminobutyric acid (GABA).  We can then use 
this device to obtain baseline concentrations from our target organisms, the crabs 
themselves. Once we have a baseline, we can apply different stimuli to the crabs and 
measure the real-time changes in concentrations of these neuromodulators from 
hemolymph samples taken from the crabs using microdialysis. 
 
In summary, we have made a microfluidic device to detect concentrations of six specific 
neuromodulators that requires small volumes of sample, yields high sensitivity, achieves 
fast detection, and is inexpensive.
2,3
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2 System 
 
2.1 System Overview 
 
Below in Figure 2.1 is an illustration of the various components of our microfluidic 
device and how they come together.   
 
 
Figure 2.1: An overview of the microfluidic device project.   
 
We used these enabling technologies and materials in the design, fabrication, and 
experimentation of our device. The PDMS (polydimethylsiloxane) forms the device 
itself, while the MEKC (micellar electrokinetic chromatography), capillary 
electrophoresis, and the carbon paste electrode technologies allow us to separate and 
detect our analytes. See Table 2.1 below for more details. 
 
Our device uses the sampling technique microdialysis.  Microdialysis is important to the 
use of our device because it allows for continuous measurements, resulting in a higher 
time resolution.  While microdialysis can have slow sampling times, since it relies on 
diffusion, the use of microchip capillary electrophoresis will decrease the sampling time.  
Microdialysis will also allow us to filter out larger proteins and lipid chains in the 
hemolymph sample.  We will go into more detail on that later.
1,4
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Figure 2.2: The sampling technique microdialysis is placed in the pericardial sinus of the crab.  The fluid 
diffuses through a semi-permeable filter into a collection tube.  In our case, the fluid will flow into our 
device directly. 
 
 
 
 
 
 
 
Table 2.1: Enabling technologies used in our design, along with brief descriptions and summaries of how 
they will be used in our design.  
Name Description Use 
Capillary 
electrophoresis 
(CE)
5,6
 
Electric field separation of 
compounds with different 
electrokinetic properties 
Separate neuromodulators from a 
Cancer borealis hemolymph sample 
for detection 
Amperometric 
detection
5,6
 
Detection of chemicals due 
to changes in electrical 
current 
Detection of the neuromodulators 
after they have been separated by 
CE 
Micellar 
electrokinetic 
chromatography 
(MEKC)
7,8
 
A technique to separate 
compounds in CE with 
similar electrokinetic 
properties 
Separation between dopamine and 
octopamine (structural 
isomers).  Will use sodium dodecyl 
sulfate micelles 
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2.2 Device Overview 
 
Below is a simplified schematic of our device’s final design, as well as a picture of our 
device as set up for experimentation.   
 
 
Figure 2.3: Schematic of microfluidic device, features not drawn to scale. For approximate scale, the 
entire device is about 5.5cm long.   
 
 
Figure 2.4: Picture of our device in an experimental setup.  The three microclips on the left and the 
red/white alligator clips on the right are connected to platinum probes inserted into the wells.  The 
microclip on the right is connected to the palladium decoupler, and the green alligator clip is connected to 
a copper lead wire for the carbon paste electrode.   
 
We first fill our device with 1M NaOH for 20 minutes to precondition out device.  Our 
device is then filled with our 20mM TES
a
 buffer before our sample is inserted into the 
sample well.  Our fluid flows through our device in two steps.  In the load step, we set 
our sample well to 600 V and the sample waste well to 0 V and pinching voltages of 570 
V and 550 V for the buffer well and decoupler.  The fluid flows down the voltage 
                                                 
a
 (2-[1,3-dihydroxy-2-(hydroxymethyl)propan-2)yl]amino]ethanesulfonic acid). TES is a buffer with a pH 
range from around 6.8 to 8.2 
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gradient from the sample well to the sample waste well.  We then apply 600 V at the 
buffer well and 0 V at the decoupler while having a pinching voltage of 454 V and 444 V 
for the sample well and sample waste well.  This results in the fluid flow from the buffer 
well to the decoupler taking the separation volume that has our sample, down the 
separation channel to flow over the carbon electrode. 
2.3 Customer Needs and System-Level Requirements 
 
The customer needs a higher temporal resolution than already existing technologies.  Our 
device uses a smaller sample volume along with having a higher sensitivity than other 
existing technologies.  As a result, we are able to satisfy the needs of the customer. 
2.4 Benchmarking Results 
 
Current mechanisms for studying the relationship of neuromodulators in Cancer borealis 
and humans include capillary electrophoresis and liquid chromatography– mass 
spectrometry. These technologies detect amine concentrations, but suffer from poor 
sensitivity, poor time resolution, and/or high cost.  The device we have designed provides 
low cost fabrication, high time resolution, high sensitivity, and multi-analyte detection of 
bioamines in Cancer borealis. 
 
 
 
Table 2.2: Comparison of existing technologies and our device. 
Technology 
Approx. 
Sensitivity 
Sample 
Size 
Speed Cost 
Capillary Electrophoresis
9
 nanomolar (10
-9
) 
around 
100µL 
Fast Low 
Liquid Chromatography-Mass 
Spectroscopy
10
 
micromolar (10
-6
) 
around 
1mL 
Slow 
Very 
high 
Microchip Capillary 
Electrophoresis with Amperometry 
(our device) 
picomolar (10
-12
) 
around 
10-30nL 
Very 
fast 
Very 
low 
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2.5 Functional Analysis 
There are three sequential functions that our device was designed to perform: 
 
Table 2.3: Description of three main functions of our microfluidic device.  These functions happen 
separately and sequentially in practice.   
Function Description 
Sample 
loading 
The sample well is filled with the sample to be analyzed.  Current flows 
from the sample well to the sample waste well to electroosmotically fill 
the separation volume with sample. 
Analyte 
separation 
Current flows from the buffer well to the decoupler, which leads to 
electroosmotic flow and electrophoretic separation of the analytes in 
solution.  Even though current stops at the decoupler, the fluid continues 
moving. 
Analyte 
detection 
Each volume of separated analyte flows past the carbon paste electrode, 
where it is detected using amperometry.   
 
2.5.1 Sample Loading 
During the sample loading phase, our device is filled with buffer, and then sample is 
injected into the sample well. We then apply an electric field across our device, and our 
analyte is moved from the sample well to the sample waste well through a process called 
electrophoresis. In the presence of an electric field, the charged ions present in the buffer 
move towards the well set at the lower voltage.  This causes bulk flow of the sample, and 
the solution flows through the “T” segment in our device. Figure 2.4 shows a simple 
schematic of this. 
 
 
Figure 2.5: Our sample fluid flows from the sample well to the sample waste well as a result of the voltage 
gradient that we create. 
2.5.2 Analyte Separation 
Once the “T” segment of the device has sample in it, we change the direction of the 
electric field, as shown in Figure 2.5, setting the higher voltage at the buffer well, and 
ground at our decoupler. Through electrophoresis, the sample that was present in the 
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“separation volume” area of the T, is moved down the channel toward the electrode. 
Separation occurs due to the differing electrophoretic mobilities, or mobility of an analyte 
in an electric field, of the analytes in solution. This variable is affected by the molecular 
size and charge of each particle.  Equations 1 and 2 are used to calculate electrophoretic 
mobility (µp), using electrophoretic migration velocity (up), electric field strength (E), 
length from inlet to detection point (L), migration time (tr), length of capillary (Lt), and 
the voltage applied (V).  
 
(1)        (2)    
 
 
Figure 2.6: An electrode is connected to the buffer well and the decoupler so that we can create a voltage 
gradient to cause the sample to flow down the separation channel. 
2.5.3 Analyte Detection 
Detection of our analytes is achieved by oxidizing the OH groups present on our 
neuromodulators. This is done by holding our carbon paste electrode at a constant voltage 
and measuring the current across it. When a molecule of analyte comes in contact with 
our electrode, the oxygen-hydrogen bond is broken, causing the analyte to rearrange its 
structure to accommodate the new carbon-oxygen double bond, which in turn releases a 
free electron into the system. Since our analyte molecules have two OH groups, two 
electrons are released per molecule. These electrons causes the current through our 
electrode to increase slightly; the more analyte in contact with the electrode, the larger 
the increase in current. As the sample moves past the electrode and there are no more OH 
bonds to break  to free up more electrons, the current dips back to the normal level, 
giving us a spike. Since these neuromodulators move at different speeds, the current 
spikes for the different analytes will take place at different times, helping us distinguish 
how much of each neuromodulator is present in the sample. 
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Figure 2.7: The fluid flows past the decoupler and carbon paste electrode into the separation waste 
well.  As the bioanalytes flow over the carbon paste electrode, a change in current is detected. 
 
2.6 Technical Challenges 
 
There were some technical challenges that we had to solve in order for our device to be 
successful.  The challenges and solutions are described in table 2.4. 
 
Table 2.4: Technical challenges faced during the project.  This may need to be turned back into 
paragraphs if we need more detail in the explanations behind the decisions.  
Challenge Solution Explanation 
Separating 
structural isomers 
MEKC
7,8
 Sodium dodecyl sulfate could be used in 
low concentrations to form micelles that 
have a different binding affinity to each of 
the structural isomers, meaning that one 
of our analytes will move more slowly 
down the channel. 
Removing 
hemolymph 
matrix effects, 
extra proteins, 
and lipids 
Use microdialysis with 
a semi-permeable filter  
As the fluid is extracted from the crab, the 
fluid goes through a semi-permeable 
membrane that has a specific molecular 
weight cut-off to only allow the smaller 
molecules that we want through, while the 
larger proteins are filtered out. 
Quantifying 
differences in 
signals 
Conduct a large 
quantity of runs to 
develop current 
standards for set 
concentrations of 
analytes. 
Once we start getting repeatable data, we 
can run solutions spiked with set 
concentrations of analyte and measure the 
signal current. When we have enough of 
this data, we can have an idea of what 
signal we can acquire for what 
concentration. 
Electrode fouling Run a cleaning step By running a voltage sweep that goes 
9 
 
before and after each 
run.
11,12
 
outside of the normal range for oxidation 
and reduction of our analytes will serve to 
clear our electrode of any fouling. 
Bubbles in the 
device 
Ethanol runs After each session with the device, we can 
clear the separation channel with ethanol 
to prevent the buildup of unoxidized 
analyte, which will cause bubbles the next 
time the channel is filled with buffer. 
2.6.1 Separating Structural Isomers 
The structural isomers (dopamine and octopamine in figure 2.7) will move down the 
separation channel at the exact same speed, and since during detection, we can only see 
free electrons, we are unable to tell the difference between them. In order to combat this, 
we inject our samples with SDS (sodium dodecyl sulfate). This forms little spheres in the 
solution (micelles) that the bioamines stick to.  Dopamine has a higher affinity than 
octopamine which causes the dopamine molecules to be slowed down more than the 
octopamine molecules. 
 
 
Figure 2.8: The structural isomers octopamine and dopamine 
2.6.2 Hemolymph Filter 
The hemolymph sample would not be able to be flowed through the device directly after 
it was obtained from the crab because there are protein and lipid chains that will clog the 
device.  We will use microdialysis to solve this problem.  The probe, which has a semi-
permeable membrane with a specified molecular weight cut-off, is placed within the 
pericardial sinus.  The smaller molecules diffuse through according to the concentration 
gradient while the larger proteins and lipid chains are filtered out. 
 
2.6.3 Signal Differences 
Different concentrations of bioanalytes will give different current values.  In order to 
establish a current standard for different concentrations, multiple experiments for the 
same concentrations are run until repeatable data is obtained.  This is done for multiple 
concentrations for different bioanalytes. 
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2.6.4 Electrode Fouling 
After one or two experiments our carbon paste electrode will not be as sensitive at 
detecting the bioanalytes.  As a result, we cleaned the electrode by running a voltage 
sweep that goes outside of the normal ranges for the oxidation and reduction of the 
analytes, returning the electrode to its original condition. 
 
2.6.5 Bubbles in the Device 
Bubbles in our device are detrimental to our success.  One of the reasons that bubbles can 
form is a result of a buildup of analyte around the decoupler and electrode.  We flowed 
ethanol through our device after each session of experiments to prevent this buildup from 
occurring. 
 
2.7 Team and Project Management 
 
The following are the steps we are taking to ensure fair treatment among team members: 
 We scheduled meeting times in the lab when we do our research. 
 We scheduled meetings with our professor as a team where we expressed our 
concerns and ideas about the project. 
 Everyone is allowed to do everything and knows the procedure of how to do 
anything within the project, allowing for better conceptual understanding and 
problem solving within the group. 
 
Communication is key when doing any sort of group project.  We started by setting up a 
group text message thread where we could post problems, updates, and talk about 
meeting times, making sure that everyone was included and aware of what was going on 
in the lab. Since our lab space and instruments were being shared by several groups, we 
also decided to use a lab calendar to orchestrate when different groups could use the 
microscope, Chi instrument, etc. to maximize lab time and space. All of our research was 
also posted to a google document to allow multiple group members to edit and add to our 
thesis and lab materials at the same time. We feel that the steps that we have taken to 
ensure communication between team members are sufficient. 
 
Refer to the Gantt chart in appendix A for more specifics on what each person 
contributed to the project throughout the year. 
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3 Subsystems 
3.1 Wells 
The wells, illustrated in figure 3.1, in our design were made out of approximately the last 
5 mm of plastic pipette tips which we cut manually with a razor blade.  The wells were 
pushed down through holes punched in the PDMS.  Although all of the wells were 
constructed in the same way, their functions were different.  Below is a figure showing 
the locations of the wells and a table describing their functions.   
 
 
Figure 3.1: Illustration showing the locations of the four wells in the device.   
 
Table 3.1: Table describing functions of the four wells in the device. 
Well Function 
Buffer well Held extra buffer solution 
Sample well Held the sample to be analyzed 
Sample waste 
well 
Collected excess sample after it had flowed from the sample well 
during the load step 
Separation 
waste well 
Collected waste sample after it had flowed down the separation 
channel and across the detection electrode during the separation step 
 
3.2 Separation Channel 
The separation channel, shown in figure 3.2, is approximately 55mm long, 50µm deep, 
and 50µm wide. This is the length of the channel past our sample well that will allow the 
different analytes to separate based on electrophoretic mobility, or how quickly they 
move in an electric field. 
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Figure 3.2: Illustration showing the location of the separation channel and our sample volume. 
3.3 Decoupler 
The decoupler, shown in Figure 3.3, was made of 0.025 mm diameter palladium 
wire.  Palladium was chosen for its excellent electrical conductivity. We use a decoupler 
to electrically separate our grounding voltage from our carbon paste electrode. By placing 
the decoupler in front of the electrode, we make sure that any effect that the electric field 
used in electrophoresis could have on the electrode is mitigated. We did some tests to 
measure current with the decoupler placed behind the electrode, and the results prove that 
the decoupler placement is key. See figure in Appendix E. 
 
 
Figure 3.3: Illustration showing the location of the decoupler. 
3.4 Carbon Paste Electrode 
The carbon paste electrode, shown in figure 3.4, was the detection mechanism for the 
analytes once they had electroosmotically separated during their flow down the 
separation channel.  It was composed of graphite powder, multi-walled carbon nanotubes, 
mineral oil, and PDMS.  See appendix D for specific composition.
1
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Figure 3.4: Illustration showing the location of the carbon paste electrode. 
3.5 Micelles 
A small concentration of sodium dodecyl sulfate (SDS) can be added to our sample to 
separate the two structural isomers that we are quantifying, octopamine and dopamine. 
SDS forms micelles, or small spherical aggregates of around 60 monomers, in polar 
solutions. Dopamine and octopamine have different polarities due to their chemical 
structure, which causes them to have different binding affinities to the SDS micelles. The 
analyte that has a stronger affinity to the micelles will move more slowly down the 
separation channel, and so will show up as a separate peak in our amperometric detection 
step at the electrode.
7,8
 
 
3.6 Electrochemical Analyzer 
The electrochemical analyzer was used as our detection monitoring system.  The device 
we used was the CHI800D model.  While the electrochemical analyzer can be used for 
multiple applications, we chose to use it for two main techniques: cyclic voltammetry and 
amperometric detection.  Cyclic voltammetry was used to determine that our electrode 
was functional.  The main technique used was amperometric detection.  Amperometric 
detection measures the current versus the time.  As previously stated, when 
neuromodulators flow past the electrode, there is a change in current that is detected, with 
a different current peak for each neuromodulator.  We are then able to determine the 
concentrations of the different neuromodulators by measuring the current peaks.  We 
calculated the motility of each neuromodulator to determine which current peak belonged 
to each neuromodulator.  This technique is highly sensitive, which is what we were 
looking for in our device. 
 
3.7 High Voltage Sequencer 
We use a high voltage sequencer in order to move our sample through the device. We 
have four leads coming from the sequencer: one for the buffer well, sample well, sample 
waste well, and one connected to the decoupler.  We used platinum wire for the 
electrodes that were in the wells while the lead for the decoupler was connected 
directly.  Voltage was applied to the device which in turn created electroosmotic 
flow.  The neuromodulators were separated based on their charge.  Positive molecules 
travel the fastest followed by neutrally charged molecules and negatively charged 
14 
 
molecules.  Electroosmotic flow is preferred to pressure-driven flow because the 
neuromodulators move in a “plug-like” profile while pressure driven flow moves the 
neuromodulators in a parabola like profile.  The electroosmotic flow will give our device 
a higher sensitivity and better time resolution.   
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4 System Integration, Test 
4.1 Fluorescent Test 
 
Before we jumped straight into measuring bioanalytes through amperometric detection, 
we wanted to make sure that the fluid would flow in the correct direction.  To determine 
this, we ran our experiment with fluorescein-dextran, figure 4.1, so that we could visually 
see the fluid flow through the channel. 
 
 
Figure 4.1: Fluorescent 40x magnification images of double T sample injector filled with fluorescein-
dextran by EOF. (1-3) Right leads to CE separation channel, top leads to sample waste reservoir, left leads 
to buffer reservoir, and down leads to sample reservoir. 
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4.2 Cyclic Voltammetry 
 
We also wanted to determine that our carbon paste electrode would be able to detect the 
bioanalytes through a change in current.  We checked this first through cyclic 
voltammetry.  The results of that experiment our illustrated in figure 4.2. 
 
 
Figure 4.2: CV conducted for our carbon paste electrode.  Working electrode was the carbon paste, 
counter and reference electrode were the Pd wire decoupler.  The straight lines around 0 microamps show 
when the solution only consisted of the buffer.  When a drop of 1 mM dopamine was added to the solution, 
the current was able to fluctuate between around 0.2 and -0.3 microamps. 
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4.3 Amperometric Detection 
4.3.1 Pressure Driven Flow 
 
We checked that our carbon paste electrode could also detect the bioanalytes as the fluid 
flowed through the channel.  This was done through amperometric detection using 
pressure driven flow from a syringe at the buffer well.  The results are shown in figure 
4.3. 
 
 
Figure 4.3: Amperometric detection of 1mM dopamine solution using electroosmotic flow for the load step, 
and pressure driven flow for the separation step. 
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4.3.2 Spiked Dopamine Runs 
 
Now that we were able to confirm that our fluid was flowing in the correct direction and 
that our carbon paste electrode could detect these bioanalytes, we experimented using 
amperometric detection with electroosmotic flow.  Figure 4.4 and figure 4.5 show our 
experiments using a 1 mM spiked dopamine solution. 
 
Figure 4.4: Amperometric detection of 1mM dopamine solution using electroosmotic flow for the load and 
separation step. Note the wide sloping peak, and the uneven fall off in current after the analyte has passed. 
Most likely caused by current continuing to leak from the separation well, causing uneven flow of analyte 
down the channel. 
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Figure 4.5: Amperometric detection of 1mM dopamine solution using electroosmotic flow for the load and 
separation step. This steep peak shows the desired increase in current, but the other smaller spikes after the 
large one are also from dopamine (the only analyte in the solution), and are most likely caused by a faulty 
separation step. 
 
4.3.3 Catechol Run 
We also tried our experiments with catechol instead of dopamine and got similar results. 
 
 
Figure 4.6: Amperometric detection of 1mM catechol solution using electroosmotic flow for the load and 
separation step. The sharp increase in current shown is what we expect, however the slow fall off could 
indicate a faulty separation step as well. Note how the catechol peak occurs around 22 seconds after the 
separation step, while the dopamine runs took between 12 and 14 seconds. This is expected, because 
catechol is neutral at this pH, and therefore has a lower electrophoretic mobility. 
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4.4 Platinum Node Test 
 
In order to determine that our platinum nodes were all working the same, we ran some 
current tests through our device to measure the currents that each platinum node was 
giving off as well as receiving.  Figure 4.7 illustrates the result of one of these tests.  We 
did the same experiment on all the platinum nodes and got similar results. 
 
 
Figure 4.7: We had one electrode in the sample well (ch. E) and another electrode in the sample waste well 
(ch. H).  We applied 600 V to ch. E and 0 V at ch. H.  We then reversed the voltages around 8 sec. We did 
this test multiple times and swapped different platinum nodes for each test.  Each test gave similar results. 
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4.5 Known Resistor Voltage Test 
 
When checking our voltage sequencer to see if it was giving off the correct current, we 
connected our instrument to a known resistance of 30 MΩ. We ran multiple voltages 
through the circuit and measured the currents that the voltage sequencer instrument 
software gave us.  We compared these to the theoretical values.  The difference between 
the two values versus the voltage is shown in figure 4.8. 
 
 
Figure 4.8: We connected our high voltage sequencer to a known resistance of 30 MΩ and measured the 
current at different voltages. We compared that to the current that we expected. 
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5 Discussion 
 
The first experiment that we ran with our device was to use fluorescent dye instead of our 
crab sample to verify that our fluid was travelling in the correct direction.  As shown in 
figure 4.1, we did get the fluorescent dye to flow in the correct directions for the load step 
and separation step.  We then moved on to amperometric detection through 
electroosmotic flow of a stock solution of 1 mM dopamine.  Unfortunately, we were not 
able to get very favorable results.  We were able to get the load step to work almost every 
time, but the separation step was inconsistent.  There were a few experiments which gave 
potential dopamine peaks, but there was either so much noise that we could not say with 
certainty that the peaks were a result of the dopamine being detected at the electrode, or 
the current would increase quickly and then decrease slowly, which was most likely a 
result of dopamine leaking into the separation channel from the other channels.  
 
We hypothesized that the potential problems with our device could be with the carbon 
paste electrode, the platinum nodes, or the voltage sequencer.  In order to determine that 
the carbon paste electrode could detect bioanalytes we first performed cyclic 
voltammetry (CV).  Figure 4.2 shows that when dopamine was added to the solution 
during CV, the stereotypical “anode” and “cathode” peaks were present, showing at 
which current the dopamine molecules were getting oxidized and reduced respectively.  
This tells us that our electrode is capable of holding detecting the current change when 
these two phenomena occur. 
 
We could then conclude that our carbon paste electrode was able to detect the 
dopamine.  We also wanted to verify that the carbon paste electrode could detect 
dopamine as it was flowed over it.  We tested this by doing a pressure driven flow 
test.  We conducted the load step as we normally would using electroosmotic flow, but 
instead of using electroosmotic flow for the separation step, we used a syringe at the 
buffer well to push the sample down the separation channel and past the carbon paste 
electrode.  Figure 4.3 shows the results of this test. 
 
With the positive result we were able to conclude that carbon paste electrode was not the 
problem.  We then tested the platinum nodes to see if those could be the problem.  To do 
this we used sandpaper to rub off any residue that could be on the platinum wire and then 
immersed them in ethanol.  The load step was performed with each of the platinum wires 
to determine if there was any difference between them.  Figure 4.7 shows the current that 
was detected for one of the tests, and the other test give similar results.  This led us to 
conclude that since all of the platinum nodes acted the same, they were not the 
problem.  The last component we tested was the voltage sequencer.  A known resistor of 
30 MΩ was connected to the voltage sequencer and the current was measured at different 
voltages.  Figure 4.8 shows that we determined a false positive current coming from the 
voltage sequencer.  The voltage sequencer is part of the problem, and we will continue to 
test other components to determine if there are other problems.   
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Some improvements that we will incorporate to our project in the future is first to try our 
experiments with a different voltage sequencer to determine if that solves our 
problems.  If that does solve our problems, we will move forward with detecting 
dopamine using amperometric detection and eventually use a hemolymph sample in our 
device that separates multiple bioanalytes.  If it does not solve all of the problems, we 
will attempt to change the design of our device.  There will be another group next year 
that will continue this project, and we intend to leave them with the knowledge necessary 
to address these issues. 
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6 Cost Analysis 
 
A large budget is not needed to make our device (refer to appendix C).  In actual practice, 
our device costs even less to make than what the budget illustrates because hundreds of 
devices can be made using our budget.  This accomplishes our goal of making an 
inexpensive device.  The only drawback is that in order to detect the neuromodulators 
using our device, a high voltage sequencer and an instrument that uses amperometric 
detection is needed.  These two pieces of equipment can be very expensive with them 
costing over $10,000 each.  However, while it may be a large investment at the 
beginning, we could amortize the cost of the equipment. 
 
  
25 
 
7 Engineering Standards and Realistic Constraints 
 
7.1 Ethics 
 
Ethics is an important topic to look at when creating an invention. Our team is acting 
ethically when it comes to our project because our project is for the purpose of making a 
better world and there are no materials or resulting devices that cause harm to anyone. 
The only ethical concern that people might have is that we use crabs for our experiment, 
and there have been some studies that show that crabs could feel pain. 
 
One big issue with animal testing is whether or not the animals are sentient. Sentience is 
a difficult term to define, but it’s generally understood to mean that the organism can 
distinguish itself from others. It is unknown as to when a nervous systems becomes 
complex enough to be known as ‘self-aware’. Generally, most mammals and some birds 
are considered sentient, but the invertebrate world is not generally considered to possess 
this attribute. There have been some studies that allow for the possibility of cuttlefish and 
octopi being sentient, but given our current knowledge, we don’t think that insects and 
worms, or the crabs that we use for our samples, are self-aware. Whether or not the crabs 
feel pain however, is another issue entirely. 
 
According to a few studies (one most recently Dr. Elwood at the Queens University 
Belfast in the UK), crabs exhibit a type of avoidance behavior that has been associated 
with feeling pain.
13
 During Dr. Elwood’s study, crabs were given mild shocks when they 
entered one type of shelter over another, and after repeated trials, the crabs were far more 
likely to avoid the shelter types that had shocked them and would prefer to seek shelter 
elsewhere. A similar test was done on mice, and the evidence gleaned from these 
experiments supported the case that mice do feel pain, prompting many quality-of-life 
changes to allowed testing procedures. While not being completely harmless, our 
procedure is designed to be quick and effective, and gives the crabs time to get used to 
the dialysis probe before starting to take samples. We also attempt to numb the crab by 
placing them in cold water and ice for almost 20 minutes before performing our surgery. 
We do have to poke a small hole through the shell in order to insert the probe however, 
and this approach may cause trauma to the animal. If this procedure causes the crabs too 
much pain, we might need to change the way that we get samples, or chose another 
sample organism outright. 
 
After we acquire enough data to establish what the baseline (normal state) concentrations 
of these neuromodulators are, then large changes in certain hormones that we are testing 
for might indicate that we are causing too much pain. Norepinephrine (NE) and dopamine 
(DA) for example, are two of our analytes that we could use to determine our impact on 
the crabs. Norepinephrine is a stress hormone that is responsible for the fight or flight 
response, as well as increasing heart rate and blood pressure. Dopamine has many tasks, 
but is the hormone that is most responsible for the sensation of pleasure. A steep increase 
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in NE, or a precipitous drop in DA concentrations could indicate that we are causing too 
much trauma to our subject. 
 
If that is the case, we could attempt to further numb the crabs with general anesthesia 
before inserting the probe into their shells. This would be more expensive (on account of 
the need to purchase the drug), and would most likely ruin any data that we would 
attempt to acquire over the next few days, as the anesthetic would take time to break 
down inside the organism. If this doesn’t work, we could always just take the frozen 
hemolymph samples from the physics department after they have already ‘sacrificed’ the 
crabs for their neurobiology research. Unfortunately this method would severely limit any 
post detection analysis that we could conduct because all of our data would be from dead 
crabs, preventing us from seeing any changes in neuromodulator concentrations due to 
altered environments. 
 
7.2 Social 
 
We have an ethical duty to our potential users to make the device safe to use. If we start 
to take advantage of our user’s welfare then we have gone too far and need to rethink 
what we are doing. There is always some sort of ethical responsibility that a company has 
for using a product or service. Even though the customer is using it, there is still the 
responsibility of the company to not sell them an unethical device. Now if the user starts 
to change the manufactured settings, then it becomes primarily the user’s responsibility. 
Our device does not have any unintended consequences. It detects concentrations of 
different bioamines. If someone decided to change it and detect concentrations of 
something else, we see no problem with that in itself. 
 
7.3 Environmental 
 
When creating an invention, it is important to consider if the device itself will be 
environmentally friendly.  Our device is created out of PDMS which, while non-
biodegradable, does not have any harmful effects towards organisms.  In fact, it is in 
some fast food products.   
 
7.4 Health & Safety 
 
There are two main risks pertaining to our project: shocking ourselves with the voltage 
sequencer and accidentally sticking ourselves with a needle.  In order to ensure safety 
while using the voltage sequencer, we announce to everyone around that we are going to 
turn on the sequencer so that everyone knows not to touch the leads.  Also, we make sure 
to only touch one lead at a time so as not to accidentally complete the circuit if the 
sequencer happened to be on.  With the needles we just make sure to never point them 
towards anybody, and to constantly keep them covered when not in use. We also use low 
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concentration sodium hydroxide to clean our device between runs, and 98% ethanol to 
remove dust particles from our working surfaces. Other than those risks, there are not any 
other concerns because aside from the sodium hydroxide, our materials are not bioactive. 
 
7.5 Economic 
 
When thinking about who the consumers of our product would be, we came to the 
conclusion that it would most likely be people in the developing world.  As a result, we 
wanted to make our device affordable to that type of consumer.  The materials that we 
chose were a big factor because we did not want them to be really expensive.  We chose 
to use PDMS because it is affordable and has been known to be used for similar 
applications.  We also had to consider the other instruments that would need to be used in 
addition to our device.  Unfortunately, the voltage sequencer and electrochemical 
analyzer are not very affordable, but that is a challenge for all microfluidic systems. 
 
7.6 Aesthetics 
 
Our design is more for the functionality than the aesthetics, but our device design (Figure 
2.2) is a very simple and symmetrical device.  It is small and does not require very much 
skill to use.  The look of the device is not the most attractive thing, but as we make 
progress we can make a shell for the device so as to make it more appealing and look 
simpler.  But one thing that does make our device aesthetically pleasing is its simple, 
straightforward design in performing a complex task: the detection of bioamines.  The 
approach we used is aesthetically impressive because it is an elegant and sensitive 
solution to a problem traditionally solved with larger, more expensive technologies. 
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8 Summary 
 
We are involved in a joint project with the physics department and chemistry department 
that is studying the effects of neuromodulators common to the crab Cancer borealis.  We 
aimed to create a device that had a temporal resolution, which in turn would provide an 
accurate baseline of neuromodulators in the crab.  Our finished device seeks to have fast 
detection, be highly sensitive, require small sample volumes while maintaining 
affordability.  The use of PDMS, microchip capillary electrophoresis, carbon paste 
electrode, and MEKC are all components that will help to achieve that goal.  The new 
accomplishments that we achieved this year were the following:   
 
 Established the PDMS-PDMS bonding procedure. 
 Created multiple channel and electrode master molds using photolithography 
techniques, which was much cheaper than ordering them from Stanford. 
 Attained successful fluorescent dye test showing the flow of the fluid in the 
correct direction. 
 Successful pressure driven flow test, showing that we can detect bioanalytes using 
amperometric detection with small sample volumes. 
 
These new accomplishments will help the next group who takes on this project to truly 
focus on figuring out the amperometric detection with electroosmotic flow with our 
device.  Once that can be accomplished, more extensive tests will be feasible with 
multiple bioanalytes and eventually hemolymph sample from the crab Cancer 
borealis.  This will allow for a baseline of neuromodulator levels to be established, 
allowing researchers to see how different stimuli affect these neuromodulator 
levels.  Eventually, this device could potentially be used for similar tests in humans. 
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10 Appendices 
Appendix A: Gantt Chart 
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Appendix B: Risks and Mitigations 
 
Table B.1: Risks and Mitigations 
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Appendix C: Budget 
 
Table C.1: Budget 
Item Use Amount Amount Actual 
PDMS Mix Forms Device 5 x 0.5 kg $216.00 $327.00 
Palladium 
decoupler (.05 
mm) 
Disrupts Applied 
Potential 
2 m $326.00 $271.00 
Epoxy 
Secures 
wires/insulation 
8 pack $52.00 $0.00 
Scalpel Cuts device to size 2 pack $20.00 $8.00 
Tubing 
Used during 
testing 
1 m $8.00 $0.00 
Pipet tips Used as the well  $16.00 $34.00 
Weigh boats 
Used to mix 
chemicals 
200 pack $30.00 $0.00 
Hole Punch 
Forms well for 
injection site 
2 $30.00 $0.00 
Masks Design mold 3 $100.00 $95.00 
Tape 
Removing excess 
carbon paste 
12 rolls $24.00 $0.00 
Maintenance   $300.00 $0.00 
Shipping   $50.00 $0.00 
Stanford mold 
Mold to make 
devices 
1  $301.00 
Cleanroom 
wipes 
No lint wipes to 
wipe up liquid 
300 pack  $16.00 
TOTAL   $1,172 $1,052 
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Appendix D: Fabrication Procedure14,15 
 
Device fabrication takes place in several steps. 
Mold Fabrication 
Blue film mold. For our electrode side slab, we used a mold that we created ourselves. By 
using the mask from Dr. Abbyad’s mold, we were able to print 50µm blue film onto a 
glass slide, that we then developed using UV light using the following procedure: 
 
1. Cover one side of a 3”x2” glass microscope slide with 50µm UV-sensitive blue 
film, making sure that there are no bubbles present. 
2. Fold a piece of regular printer paper in half and place the glass slide inside the 
folded halves.  Run the paper and slide through a heat laminator (speed 6 for our 
laminator).   
3. Carefully align the mold mask on top of the blue film and expose with UV light 
for three seconds. 
4. Develop in 1% potassium carbonate solution for about 5 minutes by submerging 
the mold in the solution and then vigorously squirting the the surface of the mold 
with a pipette.  Pay close attention to the amount of undeveloped blue film on the 
surface, and stop developing immediately once it has all been dissolved.   
 
For the other side of our device, the channel side, we used a mold that we bought from 
Stanford. The longer, thinner channel gave us much more trouble, and we would often 
over or under develop our mold, and be forced to start over. By ordering a SU-8 mold 
from Stanford, we added a little cost to our project, but removed a large source of error in 
the fabrication of our device. 
 
PDMS Curing 
After our molds are created, we measure out silicon base and binder in a ratio of 10:1, 
allowing for approximately 20g of PDMS per device we are trying to make. Before 
pouring the uncured PDMS onto the mold, we make sure to vigorously mix the base and 
binder together. Once the PDMS is poured onto the mold, we place the mold into a 
vacuum desiccator to pull out the air bubbles that are dissolved in the uncured PDMS 
before it hardens. After about an hour in the desiccator, we transfer the mold over to the 
78º oven for 4 hours to completely cure it. 
 
Device Prepping 
After the PDMS has cured in the oven, we cut out the slabs from the extra PDMS and 
pull them off of the mold. We then make the carbon paste electrode by taking a drop of 
the uncured PDMS from the mixing bowl and an equal weight of mineral oil in a dish. 
Graphite powder and MWCNT (multi-walled carbon nanotubes) are then added in a 10:1 
ratio to equal the mass of the mineral oil and uncured PDMS together. This is then mixed 
very well until it is of even consistency. 
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Then we screen print our electrode slot with the carbon paste mixture, ensuring that only 
the correct amount of paste is on our device by pulling excess layers off with strips of 
Scotch tape. 
Whenever our slabs are not in use, we cover the printed side with a layer of scotch tape to 
prevent dust from getting caught in our channel. 
After our electrode has been printed, we need to insert our palladium decoupler into the 
decoupler slot. To accomplish this, we carefully cut into the decoupler slot along the edge 
of the device with a razor blade, and then pull the wire into these slots and around the 
back of the device, taping it off at both ends. 
 
Bonding16 
After the decoupler has been secured inside its slot, we bring the two unbonded slabs to 
the plasma bonder. We punch 1mm holes through each of the wells to allow for 
connections to the outside of the device once the pieces are bonded together. We then 
remove the protective tape and place the slabs face up into the plasma bonder. 
In order to secure a good vacuum and good plasma, we turn on both the pump and the 
plasma cleaner at the same time, and then do not turn the actual plasma on until the 
pressure inside the chamber is below 300 mtorr. When this threshold is passed, we turn 
off the vacuum and turn the plasma on high, allowing a small inlet to form, increasing the 
quality and volume of the plasma (displayed by a rosy pink color), which we maintain for 
50 seconds. We then turn off the plasma and the plasma cleaner, and open the door after 
the vacuum has been released. 
The two sides of the device are firmly pressed together and then this process is repeated 
to bond a glass slide to the back of the device, adding structural support. 
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Appendix E. Current without Decoupler 
 
Figure E.1: Amperometric detection step of purely buffer solution using a device without a decoupler. The 
two step level currents are purely generated by the field present in the load step (the lower currents) and 
the separation step (the higher currents). This shows the necessity of having a decoupler before the 
electrode. 
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Appendix F: Material Sources 
 
Table F.1: List of the instruments and materials we used from other suppliers. 
Item Supplier Item Number 
Electrochemical Analyzer CH Instruments CHI800D 
Voltage Sequencer LabSmith HVS448-6000D 
Palladium (decoupler) Goodfellow PD005113 
Pipette tips (wells) Fisher Scientific 02-707-447 
Photolithography mask CAD/Art Services N/A 
 
